The Opko Health (OPK) price analysis
Opko Health (OPK) currently trades at $1.69 and has grown by 3.71% today. OPK went up $0.06 from the previous closing price of $2.91. The high forecast for Opko Health is $6.00 and the low is $3.00. The company’s market cap is $1.13 billion with a 52 week high of $2.91 and a 52 week low of $1.12. OPK has changed in price by -0.77 per share in the last 12 months.
Opko Health has a weak EPS of -0.53. This means the company lost $-0.53 per share after paying dividends, this can indicate that the stock is a risky investment. EPS is calculated as a company’s profit divided by the outstanding shares of its common stock. The resulting number serves as an indicator of a company’s profitability. It is common for a company to report EPS that is adjusted for extraordinary items and potential share dilution. Based on this information, investorsQ rates this stock 4 out of 10. We give it this rating based on current information written in this article.
About Opko Health:
OPKO Health is a diversified healthcare company present in more than 30 countries. The company’s primary businesses include: Bioreference Laboratories, the third largest clinical laboratory with a core genetic testing business and a nearly 300 person sales and marketing team.